ALLOVIR CLASS ACTION LAWSUIT: THE SIX MOST paramount THINGS SHAREHOLDERS NEED TO KNOW AT THIS STAGE

If you suffered losses in AlloVir stock, contact AlloVir stock loss lawyer Timothy L. Miles about an AlloVir lawsuit

INTRODUCTION TO THE ALLOVIR CLASS ACTION LAWSUIT

Contact us today for a free case evaluation if you suffered losses in Allovir stock

​The AlloVir class action lawsuit seeks to represent purchasers or acquirers of AlloVir, Inc. (NASDAQ: ALVR) securities between March 22, 2022 and December 21, 2023, inclusive (the “Class Period”).  Captioned Zerbato v. AlloVir, Inc., No. 24-cv-10152 (D. Mass.), the AlloVir class action lawsuit charges AlloVir and certain of AlloVir’s top executives with violations of the Securities Exchange Act of 1934.
​​
If you suffered losses in AlloVir stock and wish to serve as lead plaintiff in the AlloVir class action lawsuit, or just have general questions about your rights as a shareholder, please contact AlloVir Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at [email protected] or by submitting a contact form. Lead plaintiff motions for the AlloVir class action lawsuit must be filed with the court no later than March 19, 2024.

In this guide, we will address the six most paramount things shareholders in the AlloVir class action lawsuit need to know at this early stage of the litigation.

---

WHAT IS THE LEAD PLAINTIFF DEADLINE IN THE ALLOVIR CLASS ACTION LAWSUIT?

​​When a securities class action is filed such as the AlloVir class action lawsuit, the person who files the first complaint is required to publish a notice announcing the filing. Anyone who wants to be lead plaintiff on behalf of the class in the AlloVir class action lawsuit must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published. 

​Lead plaintiff motions for the AlloVir class action lawsuit must be filed with the court no later than March 19, 2024.

WHAT IS THE LEAD PLAINTIFF PROCESS IN THE ALLOVIR CLASS ACTION LAWSUIT?

​The PSLRA permits any investor who purchased and suffered losses in AlloVir​ stock to seek appointment as lead plaintiff in the AlloVir class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. ​

​A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the securities class action lawsuit.  An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff. If you suffered losses in AlloVir​ stock and have further questions, contact AlloVir stock loss Lawyer Timothy L. Miles today who would fight to recover your damages in an AlloVir class action lawsuit if you suffered losses in AlloVir stock.

CAN A NON-U.S. INVESTOR SERVE AS LEAD PLAINTIFF IN THE ALLOVIR CLASS ACTION LAWSUIT?

​Yes, courts in the U.S. have consistently recognized that non-U.S. investors, many of whom have substantial holdings, are adequate lead plaintiffs and have the same right to move for lead plaintiffs as U.S. investors.  Thus, if a non-U.S. investor suffered losses in AlloVir​​ stock, they may move the Court to be appointed lead plaintiff in the AlloVir class action lawsuit. 

WHAT ARE THE BENEFITS OF SERVING AS LEAD PLAINTIFF IN THE ALLOVIR LAWSUIT?

Serving as a Lead Plaintiff in the AlloVir lawsuit has several important benefits and advantages including:

• A Lead Plaintiff is able to negotiate more competitive attorney fees and reduce other litigation costs by actively monitoring the class counsel.
• Lead Plaintiff has the benefit of being able to manage the litigation primarily by overseeing and monitoring the progress of the action and the efforts of counsel, and being able to review and comment on important filings and other documents pertaining to the prosecution of the action.
• There is no financial risk in serving as a Lead Plaintiff because Lead Counsel advances all costs and expenses incurred in the prosecution of the case and will be reimbursed only if there is a successful settlement or judgment recovery on behalf of the class.
• Lead Plaintiff has the benefit of being involved and active in all negotiations relating to any settlement.
• Lead Plaintiffs that continue owning the stock of the defendant will enjoy the long-term benefits from governance reform resulting from the litigation. 

Thus, there are numerous benefits and other advantages to serving as lead plaintiff in a class action against AlloVir​ if you suffered significant losses in AlloVir​​ stock. ​

WHAT RESPONSIBILITIES WILL THE LEAD PLAINTIFF HAVE IN THE ALLOVIR CLASS ACTION LAWSUIT?

​​A Lead Plaintiff owes a fiduciary duty to the class, and therefore, must act in the best interest of the class in the AlloVir class action lawsuit.  Some of the responsibilities of the Lead Plaintiff in the AlloVir class action lawsuit. include:

• Selecting, monitoring, and overseeing Lead Counsel.
• Reviewing and commenting on court filings on behalf of the class.
• Discussing litigation strategies with the Lead Counsel.
• Attending depositions (if necessary) and giving a deposition.
• Attending hearings (if necessary).
• Participating in mediation and the trial (if necessary).
• Provide input on any decision concerning the settlement of the securities class action.

WILL THE LEAD PLAINTIFFS GET MORE MONEY THAN CLASS MEMBERS IF THE ALLOVIR CLASS ACTION LAWSUIT SETTLES?

No, but they may be entitled to recover their reasonable expenses incurred with are directly related to representing the class in the AlloVir class action lawsuit. Under the PSLAR, a Lead Plaintiff is only entitled to his or her pro rata share of any recovery and does not receive any additional money for serving as a representative party on behalf of the class.  However, a court, in its discretion, may approve an award of “reasonable costs and expenses (including lost wages)” to a Lead Plaintiff that directly relates to the representation of the class in the AlloVir class action lawsuit on behalf of investors who suffered losses in AlloVir ​stock. 

CONTACT AN ALLOVIR​ STOCK LOSS LAWYER TODAY IF YOU SUFFERED LOSSES IN ALLOVIR​ STOCK ABOUT AN ALLOVIR CLASS ACTION LAWSUIT

​If you suffered losses in AlloVir​ stock, contact AlloVir​ stock loss lawyer Timothy L. Miles today for a free case evaluation about an AlloVir ​class action lawsuit. Call today and see what an AlloVir stock loss lawyer could do for you if you suffered losses in AlloVir​​​ ​stock.

The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
​300 Centerview Dr., #247
Brentwood, TN 37027
Phone: (855) 846–6529
​Email: [email protected]

AlloVir​ stock loss lawyer Timothy L. Miles

​Nashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors,  shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,​Class Action:  Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM  (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022).  Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more.  Please visit our website or call for free anytime.

CONTACT                                                      
The Law Offices of Timothy L. Miles
Tapestry at Brentwood Town Center
​300 Centerview Dr., #247
Brentwood, TN 37027
​​Phone: (855) 846-6529
​Email: [email protected]